Test results in hand, Thrive raises $257M to push liquid biopsy toward approval
News from @thrivedetect : Series B, new investors, and progress towards a breakthrough cancer detection blood test.
Updates
Bill Maris, recruits ex-Googlers to Section 32
“COVID-19 has only made it clearer that the tools for living a healthy and good life are not fairly or humanely distributed. Recent global events have shined a light on how important Section 32’s mission is.” said Bill Maris, founder of Section 32.
Bill Maris, who started Google’s VC arm, brings on new hires.
Bill Maris talked to CNBC today about what Section 32 is investing in, looking at, thinking about –>
Our place in the future of technology and healthcare
When I started Section 32 three years ago, I wanted to create a venture fund that could focus on areas where technology can make a real difference on the most important aspects of our lives.
My last job before Section 32 was as founder and CEO at Google Ventures, and even though I loved my time there, I saw a need for a different type of fund […]
An early believer in Moderna Therapeutics on the core investing lesson behind a big coronavirus bet
CNBC interviewed our own @MichaelPellini about long-term biotech bets, avoiding reactionary investments and the undervalued diagnostics industry.
Diagnostics firm says new Covid-19 test could be used 1 million times a week
“Remember that we need to go to tens of millions per week, or even per day, but every step does count.” – @MichaelPellini
